FibroGen (NASDAQ:FGEN) is scheduled to announce Q3 earnings results on Monday, November 11th, after market close.
The consensus EPS Estimate is -$0.57 (-14.0% Y/Y) and the consensus Revenue Estimate is $31.61M (+9.0% Y/Y).
Over the last 1 year, FGEN has beaten EPS estimates 75% of the time and has beaten revenue estimates 50% of the time.
Over the last 3 months, EPS estimates have seen 1 upward revision and 4 downward. Revenue estimates have seen 3 upward revisions and 3 downward.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.